Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

TIVICAY DIN 02414945

Status: Marketed
Holder: VIIV HEALTHCARE ULC
Molecule: DOLUTEGRAVIR (DOLUTEGRAVIR SODIUM)
Available to quote

Health Canada record

Active ingredient(s)DOLUTEGRAVIR (DOLUTEGRAVIR SODIUM) 50 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCJ05AJ03 DOLUTEGRAVIR
Original market date08-Nov-2013
Current status date08-Nov-2013
SourceHealth Canada DPD

Establishment licence of the holder

ViiV Healthcare ULC — licence 101800, currently licensed, last inspection rating C (2025-09-17).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing DOLUTEGRAVIR (DOLUTEGRAVIR SODIUM)

DINProductCompanyFormStrengthStatus
02491753DOVATOVIIV HEALTHCARE ULCTabletDOLUTEGRAVIR (DOLUTEGRAVIR SODIUM) 50 MG; LAMIVUDINE 300 MGMarketed
02475774JULUCAVIIV HEALTHCARE ULCTabletDOLUTEGRAVIR (DOLUTEGRAVIR SODIUM) 50 MG; RILPIVIRINE (RILPIVIRINE HYDROCHLORIDE) 25 MGMarketed
02556782PMS-DOLUTEGRAVIRPHARMASCIENCE INCTabletDOLUTEGRAVIR (DOLUTEGRAVIR SODIUM) 50 MGMarketed
02501457SANDOZ DOLUTEGRAVIRSANDOZ CANADA INCORPORATEDTabletDOLUTEGRAVIR (DOLUTEGRAVIR SODIUM) 50 MGApproved
02511517TIVICAYVIIV HEALTHCARE ULCTablet For SuspensionDOLUTEGRAVIR (DOLUTEGRAVIR SODIUM) 5 MGMarketed
02430932TRIUMEQVIIV HEALTHCARE ULCTabletDOLUTEGRAVIR (DOLUTEGRAVIR SODIUM) 50 MG; ABACAVIR (ABACAVIR SULFATE) 600 MG; LAMIVUDINE 300 MGMarketed
02461226TIVICAYVIIV HEALTHCARE ULCTabletDOLUTEGRAVIR (DOLUTEGRAVIR SODIUM) 25 MGCancelled Post Market
02461218TIVICAYVIIV HEALTHCARE ULCTabletDOLUTEGRAVIR (DOLUTEGRAVIR SODIUM) 10 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
149132013-10-31New Drug Submission (NDS)
Request a quote for TIVICAY

How to read a Canadian DIN record